A Comprehensive Algorithm for Management of Neuropathic Pain.

Neuromodulation Neuropathic Pain Pharmacological Treatment Spinal Cord Stimulation Targeted Drug Delivery

Journal

Pain medicine (Malden, Mass.)
ISSN: 1526-4637
Titre abrégé: Pain Med
Pays: England
ID NLM: 100894201

Informations de publication

Date de publication:
01 06 2019
Historique:
entrez: 2 6 2019
pubmed: 4 6 2019
medline: 22 4 2020
Statut: ppublish

Résumé

The objective of this review was to merge current treatment guidelines and best practice recommendations for management of neuropathic pain into a comprehensive algorithm for primary physicians. The algorithm covers assessment, multidisciplinary conservative care, nonopioid pharmacological management, interventional therapies, neurostimulation, low-dose opioid treatment, and targeted drug delivery therapy. Available literature was identified through a search of the US National Library of Medicine's Medline database, PubMed.gov. References from identified published articles also were reviewed for relevant citations. The algorithm provides a comprehensive treatment pathway from assessment to the provision of first- through sixth-line therapies for primary care physicians. Clear indicators for progression of therapy from firstline to sixth-line are provided. Multidisciplinary conservative care and nonopioid medications (tricyclic antidepressants, serotonin norepinephrine reuptake inhibitors, gabapentanoids, topicals, and transdermal substances) are recommended as firstline therapy; combination therapy (firstline medications) and tramadol and tapentadol are recommended as secondline; serotonin-specific reuptake inhibitors/anticonvulsants/NMDA antagonists and interventional therapies as third-line; neurostimulation as a fourth-line treatment; low-dose opioids (no greater than 90 morphine equivalent units) are fifth-line; and finally, targeted drug delivery is the last-line therapy for patients with refractory pain. The presented treatment algorithm provides clear-cut tools for the assessment and treatment of neuropathic pain based on international guidelines, published data, and best practice recommendations. It defines the benefits and limitations of the current treatments at our disposal. Additionally, it provides an easy-to-follow visual guide of the recommended steps in the algorithm for primary care and family practitioners to utilize.

Sections du résumé

BACKGROUND
The objective of this review was to merge current treatment guidelines and best practice recommendations for management of neuropathic pain into a comprehensive algorithm for primary physicians. The algorithm covers assessment, multidisciplinary conservative care, nonopioid pharmacological management, interventional therapies, neurostimulation, low-dose opioid treatment, and targeted drug delivery therapy.
METHODS
Available literature was identified through a search of the US National Library of Medicine's Medline database, PubMed.gov. References from identified published articles also were reviewed for relevant citations.
RESULTS
The algorithm provides a comprehensive treatment pathway from assessment to the provision of first- through sixth-line therapies for primary care physicians. Clear indicators for progression of therapy from firstline to sixth-line are provided. Multidisciplinary conservative care and nonopioid medications (tricyclic antidepressants, serotonin norepinephrine reuptake inhibitors, gabapentanoids, topicals, and transdermal substances) are recommended as firstline therapy; combination therapy (firstline medications) and tramadol and tapentadol are recommended as secondline; serotonin-specific reuptake inhibitors/anticonvulsants/NMDA antagonists and interventional therapies as third-line; neurostimulation as a fourth-line treatment; low-dose opioids (no greater than 90 morphine equivalent units) are fifth-line; and finally, targeted drug delivery is the last-line therapy for patients with refractory pain.
CONCLUSIONS
The presented treatment algorithm provides clear-cut tools for the assessment and treatment of neuropathic pain based on international guidelines, published data, and best practice recommendations. It defines the benefits and limitations of the current treatments at our disposal. Additionally, it provides an easy-to-follow visual guide of the recommended steps in the algorithm for primary care and family practitioners to utilize.

Identifiants

pubmed: 31152178
pii: 5509427
doi: 10.1093/pm/pnz075
pmc: PMC6544553
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S2-S12

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2019 American Academy of Pain Medicine.

Références

Curr Opin Neurol. 2009 Oct;22(5):467-74
pubmed: 19741531
Cochrane Database Syst Rev. 2016 Jul 28;7:CD010692
pubmed: 27465317
JAMA. 2018 Mar 6;319(9):872-882
pubmed: 29509867
Clin Drug Investig. 2007;27(1):75-83
pubmed: 17177582
Neuromodulation. 2011 Jul-Aug;14(4):299-311; discussion 311
pubmed: 21992423
J Pain Res. 2010 Dec 20;4:11-24
pubmed: 21386951
Lancet Neurol. 2010 Aug;9(8):807-19
pubmed: 20650402
Pain. 2001 Nov;94(2):149-58
pubmed: 11690728
Cochrane Database Syst Rev. 2017 May 22;5:CD011669
pubmed: 28530786
Pain. 2005 Dec 5;118(3):289-305
pubmed: 16213659
BMC Neurol. 2008 Sep 16;8:33
pubmed: 18796160
Eur J Neurol. 2010 Aug;17(8):1010-8
pubmed: 20298428
Cochrane Database Syst Rev. 2017 Jun 09;6:CD007938
pubmed: 28597471
Pain. 2008 Jul 31;137(3):681-8
pubmed: 18439759
Curr Med Res Opin. 2009 Jul;25(7):1663-76
pubmed: 19485723
Int J MS Care. 2015 Mar-Apr;17(2):83-9
pubmed: 25892978
Neurology. 2003 Mar 25;60(6):927-34
pubmed: 12654955
Eur J Neurol. 2006 Nov;13(11):1153-69
pubmed: 17038030
JAMA. 2005 Jun 22;293(24):3043-52
pubmed: 15972567
Pain Physician. 2013 Apr;16(2 Suppl):S49-283
pubmed: 23615883
PM R. 2017 May;9(5):502-512
pubmed: 27915069
Neuromodulation. 2017 Feb;20(2):96-132
pubmed: 28042904
Basic Clin Pharmacol Toxicol. 2005 Jun;96(6):399-409
pubmed: 15910402
Pain Physician. 2018 May;21(3):E225-E234
pubmed: 29871378
Pain. 2011 Jan;152(1):14-27
pubmed: 20851519
Eur J Pain. 2008 Aug;12(6):804-13
pubmed: 18262450
Neurosurgery. 1996 Jun;38(6):1127-31; discussion 1131-2
pubmed: 8727142
Pain. 2010 Sep;150(3):573-81
pubmed: 20705215
Pain Ther. 2017 Dec;6(Suppl 1):35-42
pubmed: 29178033
Pain. 2013 Nov;154(11):2249-61
pubmed: 23748119
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005454
pubmed: 17943857
Neurology. 1998 Jun;50(6):1837-41
pubmed: 9633737
Ann Acad Med Singapore. 1994 Mar;23(2):129-38
pubmed: 8080219
Support Care Cancer. 2009 Apr;17(4):451-60
pubmed: 19142669
Pain. 2009 Nov;146(1-2):18-25
pubmed: 19703730
Clin Ther. 2007 Aug;29(8):1655-70
pubmed: 17919547
Can Fam Physician. 2017 Nov;63(11):844-852
pubmed: 29138154
J Pain. 2005 Apr;6(4):253-60
pubmed: 15820913
Curr Med Res Opin. 2006 Feb;22(2):375-84
pubmed: 16466610
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Pain. 1990 Feb;40(2):171-82
pubmed: 2308763
J Comp Eff Res. 2018 Jul;7(7):615-625
pubmed: 29754518
Clin J Pain. 2009 Mar-Apr;25(3):185-92
pubmed: 19333167
Pain. 2003 Jul;104(1-2):323-31
pubmed: 12855342
Clin Obstet Gynecol. 2003 Dec;46(4):797-803
pubmed: 14595221
Pain. 2005 Mar;114(1-2):29-36
pubmed: 15733628
J Am Podiatr Med Assoc. 2012 May-Jun;102(3):178-83
pubmed: 22659759
Pain. 2008 May;136(1-2):150-7
pubmed: 17703885
J Med Econ. 2013;16(1):85-95
pubmed: 22970839
Clin J Pain. 2009 May;25(4):286-92
pubmed: 19590476
Curr Med Res Opin. 2011 Jan;27(1):151-62
pubmed: 21162697
Pain Physician. 2016 Sep-Oct;19(7):429-44
pubmed: 27676660
Pain. 1995 Feb;60(2):203-16
pubmed: 7784106
Anesthesiology. 2015 Jul;123(1):191-8
pubmed: 25955980
Pain. 2015 May;156(5):958-66
pubmed: 25719617
Pain. 1986 Oct;27(1):117-26
pubmed: 3785962
Spine (Phila Pa 1976). 2009 May 1;34(10):1066-77
pubmed: 19363457
Eur J Neurol. 2007 Sep;14(9):952-70
pubmed: 17718686
Curr Pain Headache Rep. 2014 Jan;18(1):388
pubmed: 24338701
Eur J Pain. 2002;6 Suppl A:47-50
pubmed: 11888241
Pain. 2003 Sep;105(1-2):71-8
pubmed: 14499422
Medicine (Baltimore). 2018 Aug;97(31):e11761
pubmed: 30075599
Pain Res Manag. 2007 Spring;12(1):13-21
pubmed: 17372630
J Neurosci. 2001 Mar 15;21(6):1868-75
pubmed: 11245671
Pain. 2013 Dec;154(12):2616-25
pubmed: 23732189
Pain. 2008 Jun;136(3):380-7
pubmed: 17888574
Curr Med Res Opin. 2006 Oct;22(10):1911-20
pubmed: 17022849
Clin J Pain. 2002 Sep-Oct;18(5):297-301
pubmed: 12218500
Acta Neurochir (Wien). 2011 Apr;153(4):763-71
pubmed: 21116663
Br J Anaesth. 2011 Oct;107(4):490-502
pubmed: 21852280
Pain. 2005 Apr;114(3):473-81
pubmed: 15777872
Clinicoecon Outcomes Res. 2015 Oct 07;7:505-20
pubmed: 26504403
Pain. 2011 May;152(5):1090-5
pubmed: 21444153
An Bras Dermatol. 2012 May-Jun;87(3):504-5
pubmed: 22714779
Pain. 2001 Feb 1;90(1-2):47-55
pubmed: 11166969
Cochrane Database Syst Rev. 2012 Jul 11;(7):CD008943
pubmed: 22786518
N Engl J Med. 2003 Mar 27;348(13):1223-32
pubmed: 12660386
Neurology. 2006 Nov 28;67(10):1792-800
pubmed: 17130411
Lancet. 2009 Oct 10;374(9697):1252-61
pubmed: 19796802
Pain. 2012 Sep;153(9):1815-23
pubmed: 22683276
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Pain Med. 2010 Aug;11(8):1267-73
pubmed: 20704675
Cochrane Database Syst Rev. 2017 Jan 13;1:CD007393
pubmed: 28085183
Clin J Pain. 2008 Jan;24(1):51-5
pubmed: 18180637
J Pain Res. 2018 Oct 18;11:2433-2443
pubmed: 30425557
Lancet Neurol. 2015 Feb;14(2):162-73
pubmed: 25575710
Pain. 1999 Oct;83(1):85-90
pubmed: 10506675
Pain. 2017 Feb;158(2):261-272
pubmed: 27893485
J Anesth. 2018 Jun;32(3):463-478
pubmed: 29737410
Pain. 2001 May;92(1-2):147-57
pubmed: 11323136
Pain. 2007 Jul;130(1-2):66-75
pubmed: 17182183
Eur J Neurol. 2010 Sep;17(9):1113-e88
pubmed: 20402746
Curr Pain Headache Rep. 2017 Mar;21(3):15
pubmed: 28271334
Am J Med. 2009 Oct;122(10 Suppl):S13-21
pubmed: 19801048
CMAJ. 2017 May 8;189(18):E659-E666
pubmed: 28483845
Mayo Clin Proc. 2010 Mar;85(3 Suppl):S3-14
pubmed: 20194146
Cochrane Database Syst Rev. 2016 Jul 28;7:CD004598
pubmed: 27467116
Neuromodulation. 2014 Dec;17(8):711-5
pubmed: 25521165
Cochrane Database Syst Rev. 2015 Aug 31;8:CD010967
pubmed: 26329307
Neurology. 2002 Oct 8;59(7):1015-21
pubmed: 12370455

Auteurs

Daniel Bates (D)

Metro Pain Group, Victoria, Australia.

B Carsten Schultheis (BC)

Muskuloskelettales Zentrum - Interventionelle Schmerztherapie, Krankenhaus Neuwerk "Maria von den Aposteln," Mönchengladbach, Germany.

Michael C Hanes (MC)

Jax Spine & Pain Centers, Jacksonville, Florida.

Suneil M Jolly (SM)

Louisiana Pain Specialists, New Orleans, Louisiana.
New Orleans East Hospital, New Orleans, Louisiana.

Krishnan V Chakravarthy (KV)

Department of Anesthesiology and Pain Medicine, University of California San Diego Health Sciences, La Jolla, California.
Veterans Administration San Diego Healthcare System, San Diego, California.

Timothy R Deer (TR)

The Spine and Nerve Center of the Virginias, Charleston, West Virginia.

Robert M Levy (RM)

Institute for Neuromodulation, Boca Raton, Florida.

Corey W Hunter (CW)

Ainsworth Institute of Pain Management, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH